ConcertAI
Founded Year
2017Stage
Series C | AliveTotal Raised
$320MValuation
$0000Last Raised
$150M | 2 yrs agoMosaic Score The Mosaic Score is an algorithm that measures the overall financial health and market potential of private companies.
-52 points in the past 30 days
About ConcertAI
ConcertAI is a leader in clinical artificial intelligence and real-world data products within the healthcare sector. The company offers a suite of AI-driven solutions and services designed to optimize clinical trials, provide predictive patient insights, and support commercial healthcare solutions. ConcertAI primarily serves the oncology research and clinical development sectors. It was founded in 2017 and is based in Cambridge, Massachusetts.
Loading...
ESPs containing ConcertAI
The ESP matrix leverages data and analyst insight to identify and rank leading companies in a given technology landscape.
The real-world data providers market offers a variety of value propositions to the pharmaceutical industry, drug labs, and healthcare organizations. It provides access to diverse patient populations, longitudinal real-world data, and patient-powered or EHR-powered controls that can replicate real-world scenarios. This can help shorten drug development timelines, reduce patient recruitment burdens …
ConcertAI named as Highflier among 15 other companies, including Holmusk, TriNetX, and Truveta.
Loading...
Research containing ConcertAI
Get data-driven expert analysis from the CB Insights Intelligence Unit.
CB Insights Intelligence Analysts have mentioned ConcertAI in 6 CB Insights research briefs, most recently on Aug 21, 2024.
Aug 21, 2024
The clinical trials tech market mapFeb 16, 2022
The 130+ AI startups reinventing healthcareExpert Collections containing ConcertAI
Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.
ConcertAI is included in 8 Expert Collections, including Unicorns- Billion Dollar Startups.
Unicorns- Billion Dollar Startups
1,244 items
Artificial Intelligence
14,769 items
Companies developing artificial intelligence solutions, including cross-industry applications, industry-specific products, and AI infrastructure solutions.
AI 100
100 items
The winners of the 4th annual CB Insights AI 100.
Conference Exhibitors
5,302 items
Digital Health 50
150 items
The winners of the second annual CB Insights Digital Health 150.
Digital Health
11,068 items
The digital health collection includes vendors developing software, platforms, sensor & robotic hardware, health data infrastructure, and tech-enabled services in healthcare. The list excludes pureplay pharma/biopharma, sequencing instruments, gene editing, and assistive tech.
ConcertAI Patents
ConcertAI has filed 1 patent.
The 3 most popular patent topics include:
- artificial neural networks
- classification algorithms
- machine learning
Application Date | Grant Date | Title | Related Topics | Status |
---|---|---|---|---|
10/29/2021 | Machine learning, Artificial neural networks, Classification algorithms, Machine learning algorithms, Statistical classification | Application |
Application Date | 10/29/2021 |
---|---|
Grant Date | |
Title | |
Related Topics | Machine learning, Artificial neural networks, Classification algorithms, Machine learning algorithms, Statistical classification |
Status | Application |
Latest ConcertAI News
Jul 10, 2024
SAIGroup Expands Healthcare AI Platform with Acquisition of Get Well July 9, 2024 (July 9, 2024) Get Well will leverage SAIGroup’s AI technology to build the leading precision care platform for hospitals and ambulatory centers to improve outcomes for millions of patients PALO ALTO, California (July 9, 2024) – Enterprise AI investment firm SAIGroup announced today it has acquired digital patient engagement leader Get Well , which powers more than 10 million annual patient interactions at over 1,000 healthcare organizations. Get Well joins SAIGroup’s growing portfolio of AI healthcare companies, which include clinical AI and real-world data leader ConcertAI and generative AI-native precision care clinician platform RhythmX AI . As an SAIGroup company, Get Well will integrate SAIGroup’s award-winning, advanced predictive + generative Eureka AI platform into the patient experience inside and outside the hospital. SAIGroup’s RhythmX AI platform and healthcare data, including longitudinal metadata related to 300 million patients, more than 4.4 billion total annual claims, and more than 1.8 million healthcare professionals, will help Get Well enhance the patient and clinician experience at the point of care and beyond, increase clinician efficiency, and deliver precision care recommendations. Predictive and generative AI will bring a new level of precision engagement to help pioneer a new era of whole-person care through generative and predictive AI and bring new insights and capabilities to Get Well’s product portfolio and patient data set. SAIGroup Founder and CEO Dr. Romesh Wadhwani will serve as Get Well Chairman, and Michael O’Neil will continue as Get Well Founder and CEO “As part of SAIGroup, Get Well’s mission to enable the best patient experience will undergo a rapid transformation with AI to a full precision care platform for hospitals and ambulatory centers,” said Dr. Wadhwani. “This strategic investment underscores SAIGroup’s commitment to innovative AI-driven solutions in healthcare and highlights our confidence in Get Well as a leader in the digital patient engagement space.” Get Well strives to enhance the patient experience in healthcare systems through customized, holistic care that engages the patient throughout their care journey, and has proven its model works – Get Well’s award-winning solutions have driven millions of dollars in revenue for clients, decreased readmission rates by over 40%, reduced preterm births by 36% and resulted in double-digit growth in brand loyalty metrics. Get Well has driven digital patient engagement at scale for enterprise health systems like Adventist Health , Lifebridge Health , Kaiser Permanente, and Children’s Hospital of Colorado, as well as for 15 of the 17 VISNs as part of the Veterans Health Administration . “We are thrilled about this investment and the opportunity to take the Get Well portfolio to the next level,” said Michael O’Neil, Founder and CEO of Get Well. “The AI capabilities of SAIGroup will enable Get Well to accelerate our innovation roadmap and transform how healthcare providers care for and interact with patients. SAIGroup and Get Well are committed to pushing the boundaries of how generative AI can enhance digital patient engagement.” Oxford Finance provided debt financing for the transaction, and McDermott Will & Emery served as legal counsel to SAIGroup. Cain Brothers served as financial advisor and DLA Piper served as legal advisor to Get Well. About SAIGroup SAIGroup is a private firm investing in businesses with the potential to become leaders in enterprise AI. SAIGroup companies ConcertAI, SymphonyAI, and RhythmX AI deliver AI solutions that transform industries and bring value to companies, workers, healthcare professionals, and patients. The companies collectively represent a workforce of more than 4,000 talented engineers, data scientists and industry/healthcare experts. SAIGroup is backed by a $1 billion commitment from Founder and CEO Dr. Romesh Wadhwani, a noted entrepreneur and philanthropist. Learn more at saigroup.ai and follow SAIGroup on LinkedIn . About Get Well Now part of SAI Group , Get Well is redefining digital patient engagement by putting patients in control of their healthcare, inside and outside the hospital. Get Well combines advanced AI navigation with high-touch care experiences to improve patient activation, loyalty, and outcomes and reduce the cost of care. Get Well serves more than 10 million patients annually at over 1,000 hospitals and clinical partner sites, using longitudinal data analytics to better serve patients and clinicians. Get Well’s award-winning solutions were recognized again in 2024 by KLAS Research and AVIA Marketplace . Learn more about Get Well and follow us on LinkedIn .
ConcertAI Frequently Asked Questions (FAQ)
When was ConcertAI founded?
ConcertAI was founded in 2017.
Where is ConcertAI's headquarters?
ConcertAI's headquarters is located at 1120 Massachusetts Avenue, Cambridge.
What is ConcertAI's latest funding round?
ConcertAI's latest funding round is Series C.
How much did ConcertAI raise?
ConcertAI raised a total of $320M.
Who are the investors of ConcertAI?
Investors of ConcertAI include Sixth Street Partners, AllianceBernstein, Maverick Ventures Israel, Declaration Partners, SymphonyAI and 3 more.
Who are ConcertAI's competitors?
Competitors of ConcertAI include Mendel AI, Zephyr AI, Holmusk, nference, COTA and 7 more.
Loading...
Compare ConcertAI to Competitors
Owkin operates as an artificial intelligence (AI)-based biotechnology company. It utilizes AI to enhance the process of finding suitable treatments for patients. The company's main services include the use of AI to identify new treatments, accelerate clinical trials, and build diagnostic tools. It enables researchers in hospitals, universities, and the biopharmaceutical industry to understand how drug efficacy varies for the improvement of drug development. Its services primarily cater to the biopharmaceutical and academic research sectors. It was founded in 2016 and is based in New York, New York.
Promptly Health is a global provider of end-to-end Real World Evidence solutions in the healthcare sector. The company's main services include the generation of new knowledge from harmonized clinical, socio-economic, and claims data, augmented with the collection of longitudinal patient-reported data and patient-generated digital biomarkers. Promptly Health primarily sells to the life sciences sector, healthcare providers, and healthcare payers. It was founded in 2017 and is based in Porto, Portugal.
Verantos is a company that focuses on generating high-validity real-world evidence in the life sciences sector. The company offers a platform that integrates various real-world data sources and uses artificial intelligence to generate evidence with high accuracy, completeness, and traceability. This evidence is used to accelerate clinical development, market access, medical affairs, pharmacovigilance, and regulatory initiatives across all therapeutic areas. It was founded in 2015 and is based in Menlo Park, California.
Aetion operates as a healthcare analytics company. It provides decision-grade real-world evidence solutions to biopharma companies, payers, and regulatory agencies. It offers a platform that analyzes data from the real world to produce scientifically validated answers on treatments, effectiveness, and value. The company was founded in 2012 and is based in New York, New York.
Clarify Health provides an enterprise analytics and payments platform. It delivers end-to-end intelligence on every patient journey, empowering payers, providers, and life sciences companies to make better care decisions. Its platform, Atlas, maps over a million patient journeys, generates over a billion artificial intelligence (AI)-powered predictions, and delivers insights via cloud software applications. The company was founded in 2015 and is based in San Francisco, California.
xCures is a company specializing in healthcare data management, focusing on providing a platform for healthcare data access and integration. The company offers an artificial intelligence-assisted platform that can automatically retrieve, normalize, and structure medical records from various healthcare sources, providing clinically actionable insights and supporting decision-making for research and treatment. xCures primarily serves the healthcare and clinical research sectors with its comprehensive data solutions. It was founded in 2018 and is based in Oakland, California.
Loading...